Paracetamol Access Under Review
Posted on: Fri 30 Sep 2022
Paracetamol is currently under the spotlight from the Therapeutic Goods Association over concerns in the community around poisonings, particularly of young people.
The feedback process is currently underway and will be open until mid October, after which our access to this common household drug could change.
Natasa Gisev, Clinical pharmacist and Scientia Senior Lecturer at the National Drug and Alcohol Research Centre at UNSW Sydney, joins Breakfast’s Tom Mann to discuss further.
Image: Wikimedia Commons
Produced by Tom Mann
